FTC sues big pharmacy benefit supervisors over insulin rates The agency introduced motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list price of life-preserving insulin medications. Insurers will continue vertically integrating to maintain far more income in-residence, and federal scrutiny https://josuegeyzw.59bloggers.com/31052272/considerations-to-know-about-healthcare-news